...
首页> 外文期刊>Applied biochemistry and biotechnology, Part A. enzyme engineering and biotechnology >Pneumococcal Predictive Proteins Selected by Microbial Genomic Approach Are Serotype Cross-Reactive and Bind to Host Extracellular Matrix Proteins
【24h】

Pneumococcal Predictive Proteins Selected by Microbial Genomic Approach Are Serotype Cross-Reactive and Bind to Host Extracellular Matrix Proteins

机译:通过微生物基因组方法选择的肺炎球菌预测蛋白是血清型交叉反应性并与宿主细胞外基质蛋白结合

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Streptococcus pneumoniae is a colonizer of the human nasopharynx, which accounts for most of the community-acquired pneumonia cases and can cause non-invasive and invasive diseases. Current available vaccines are serotype-specific and the use of recombinant proteins associated with virulence is an alternative to compose vaccines and to overcome these problems. In a previous work, we describe the identification of proteins in S. pneumoniae by reverse vaccinology and the genetic diversity of these proteins in clinical isolates. It was possible to purify a half of 20 selected proteins in soluble form. The expression of these proteins on the pneumococcal cells surface was confirmed by flow cytometry. We demonstrated that some of these proteins were able to bind to extracellular matrix proteins and were recognized by sera from patients with pneumococcal meningitis infection caused by several pneumococcal serotypes. In this context, our results suggest that these proteins may play a role in pneumococcal pathogenesis and might be considered as potential vaccine candidates.
机译:肺炎链球菌是人鼻咽的殖民症,其占大多数社区获得的肺炎病例,可引起非侵入性和侵袭性疾病。目前的可用疫苗是特异性的,并且使用与毒力相关的重组蛋白是组成疫苗的替代方案,并克服这些问题。在先前的工作中,我们通过临床分离株通过反向疫苗学和这些蛋白质的遗传多样性来描述S.肺炎蛋白蛋白的鉴定。可以用可溶形式纯化半个选定的蛋白质。通过流式细胞术确定这些蛋白质对肺炎球菌细胞表面的表达。我们证明,一些这些蛋白质能够与细胞外基质蛋白结合,并由由几种肺炎球菌血清型引起的肺炎球菌脑膜炎感染患者血清认识到。在这种情况下,我们的结果表明,这些蛋白质可能在肺炎球菌发病机制中发挥作用,并且可能被认为是潜在的疫苗候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号